{"id":967,"date":"2025-03-10T10:58:25","date_gmt":"2025-03-10T13:58:25","guid":{"rendered":"https:\/\/oncobiomed.cl\/?post_type=noticias&#038;p=967"},"modified":"2025-03-10T13:22:01","modified_gmt":"2025-03-10T16:22:01","slug":"el-mostrador","status":"publish","type":"noticias","link":"https:\/\/oncobiomed.cl\/en\/noticias\/el-mostrador\/","title":{"rendered":"El Mostrador"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">TAPCells is an advanced therapy developed by the Oncobiomed company, which has emerged as a promising treatment for patients diagnosed with cancer and is based on personalised vaccines that stimulate the immune system.<\/span><\/p>","protected":false},"featured_media":968,"template":"","class_list":["post-967","noticias","type-noticias","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/oncobiomed.cl\/en\/wp-json\/wp\/v2\/noticias\/967","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oncobiomed.cl\/en\/wp-json\/wp\/v2\/noticias"}],"about":[{"href":"https:\/\/oncobiomed.cl\/en\/wp-json\/wp\/v2\/types\/noticias"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/oncobiomed.cl\/en\/wp-json\/wp\/v2\/media\/968"}],"wp:attachment":[{"href":"https:\/\/oncobiomed.cl\/en\/wp-json\/wp\/v2\/media?parent=967"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}